These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15105924)

  • 1. A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactions.
    Olsen J; Seiler P; Wagner B; Fischer H; Tschopp T; Obst-Sander U; Banner DW; Kansy M; Müller K; Diederich F
    Org Biomol Chem; 2004 May; 2(9):1339-52. PubMed ID: 15105924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions.
    Olsen JA; Banner DW; Seiler P; Obst Sander U; D'Arcy A; Stihle M; Müller K; Diederich F
    Angew Chem Int Ed Engl; 2003 Jun; 42(22):2507-11. PubMed ID: 12800172
    [No Abstract]   [Full Text] [Related]  

  • 3. A fluorine scan at the catalytic center of thrombin: C--F, C--OH, and C--OMe bioisosterism and fluorine effects on pKa and log D values.
    Schweizer E; Hoffmann-Röder A; Schärer K; Olsen JA; Fäh C; Seiler P; Obst-Sander U; Wagner B; Kansy M; Diederich F
    ChemMedChem; 2006 Jun; 1(6):611-21. PubMed ID: 16892401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the fluorophilicity of a hydrophobic pocket: synthesis and biological evaluation of tricyclic thrombin inhibitors directing fluorinated alkyl groups into the p pocket.
    Hoffmann-Röder A; Schweizer E; Egger J; Seiler P; Obst-Sander U; Wagner B; Kansy M; Banner DW; Diederich F
    ChemMedChem; 2006 Nov; 1(11):1205-15. PubMed ID: 17001711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
    De Simone G; Menchise V; Omaggio S; Pedone C; Scozzafava A; Supuran CT
    Biochemistry; 2003 Aug; 42(30):9013-21. PubMed ID: 12885234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine interactions at the thrombin active site: protein backbone fragments H-C(alpha)-C=O comprise a favorable C-F environment and interactions of C-F with electrophiles.
    Olsen JA; Banner DW; Seiler P; Wagner B; Tschopp T; Obst-Sander U; Kansy M; Müller K; Diederich F
    Chembiochem; 2004 May; 5(5):666-75. PubMed ID: 15122639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition.
    Dullweber F; Stubbs MT; Musil D; Stürzebecher J; Klebe G
    J Mol Biol; 2001 Oct; 313(3):593-614. PubMed ID: 11676542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors.
    Schweizer E; Hoffmann-Röder A; Olsen JA; Seiler P; Obst-Sander U; Wagner B; Kansy M; Banner DW; Diederich F
    Org Biomol Chem; 2006 Jun; 4(12):2364-75. PubMed ID: 16763681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
    Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
    J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
    Obst U; Banner DW; Weber L; Diederich F
    Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S1 subsite in snake venom thrombin-like enzymes: can S1 subsite lipophilicity be used to sort binding affinities of trypsin-like enzymes to small-molecule inhibitors?
    Silva FP; De-Simone SG
    Bioorg Med Chem; 2004 May; 12(10):2571-87. PubMed ID: 15110839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and X-ray crystal structures of human thrombin with synthetic cyanopeptide-analogues.
    Radau G; Fokkens J
    Pharmazie; 2007 Feb; 62(2):83-8. PubMed ID: 17341023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding organofluorine chemistry. An introduction to the C-F bond.
    O'Hagan D
    Chem Soc Rev; 2008 Feb; 37(2):308-19. PubMed ID: 18197347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.
    Marinko P; Krbavcic A; Mlinsek G; Solmajer T; Bakija AT; Stegnar M; Stojan J; Kikelj D
    Eur J Med Chem; 2004 Mar; 39(3):257-65. PubMed ID: 15051174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability.
    Staas DD; Savage KL; Sherman VL; Shimp HL; Lyle TA; Tran LO; Wiscount CM; McMasters DR; Sanderson PE; Williams PD; Lucas BJ; Krueger JA; Lewis SD; White RB; Yu S; Wong BK; Kochansky CJ; Anari MR; Yan Y; Vacca JP
    Bioorg Med Chem; 2006 Oct; 14(20):6900-16. PubMed ID: 16870455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
    Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
    J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing complexes with F-Li+-F lithium bonds: structures, binding energies, and spin-spin coupling constants.
    Del Bene JE; Alkorta I; Elguero J
    J Phys Chem A; 2009 Jul; 113(29):8359-65. PubMed ID: 19569706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of mixed substituents on the macrocyclic ring distortions of free base porphyrins and their metal complexes.
    Bhyrappa P; Arunkumar C; Varghese B
    Inorg Chem; 2009 May; 48(9):3954-65. PubMed ID: 19334709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of structural-kinetic and structural-thermodynamic relationships for thrombin inhibitors.
    Winquist J; Geschwindner S; Xue Y; Gustavsson L; Musil D; Deinum J; Danielson UH
    Biochemistry; 2013 Jan; 52(4):613-26. PubMed ID: 23290007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.